Back
Apollo Global Management, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
16
APO
Apollo Global Management, Inc.
Last Price:
$106.17
Seasonality Move:
7.58%
Sell
27
NVO
Novo Nordisk A/S
Last Price:
$36.97
Seasonality Move:
12.55%
Sell
16
Apollo Global Management, Inc. (APO)
is a Sell
Is Apollo Global Management, Inc. a Buy, Sell or Hold?
-
The current Apollo Global Management, Inc. [APO] share price is $107.04. The Score for APO is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
APO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $36.98. The Score for NVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APO Stock Price Chart
What is Apollo Global Management, Inc.'s stock price today?
-
The Apollo Global Management, Inc. share price today is $107.04Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APO is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $36.98Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
APO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.04 | Sell |
| Relative Strength Index (14 RSI): | 40.88 | Sell |
| Chaikin Money Flow: | 433712 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (105.56 - 111.28) | Sell |
| Bollinger Bands (100): | (114.26 - 143.54) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.87 | Sell |
| Relative Strength Index (14 RSI): | 39.83 | Sell |
| Chaikin Money Flow: | 14566902 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.41 - 38.59) | Sell |
| Bollinger Bands (100): | (39.84 - 55.48) | Sell |
APO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.76 | Sell |
| 20-day SMA: | 108.57 | Sell |
| 50-day SMA: | 117.91 | Sell |
| 200-day SMA: | 132.88 | Sell |
| 8-day EMA: | 109.41 | Sell |
| 20-day EMA: | 110.37 | Sell |
| 50-day EMA: | 116.99 | Sell |
| 200-day EMA: | 129.49 | Sell |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.4 | Buy |
| 20-day SMA: | 37.4 | Sell |
| 50-day SMA: | 44.19 | Sell |
| 200-day SMA: | 53.09 | Sell |
| 8-day EMA: | 36.61 | Buy |
| 20-day EMA: | 37.8 | Sell |
| 50-day EMA: | 42.18 | Sell |
| 200-day EMA: | 54.43 | Sell |
Apollo Global Management, Inc. Earnings Growth & APO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.17 per share, an increase this year of $1.21 per share, and an increase next year of $1.60 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.05 per share.
Apollo Global Management, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||